• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Cardiovasc Imaging . Cardiac Phenotyping of SARS-CoV-2 in British Columbia: A Prospective Echo Study With Strain Imaging

tetano

Editor, Senior Moderator
J Cardiovasc Imaging


. 2023 Jul;31(3):125-132.
doi: 10.4250/jcvi.2022.0120. Cardiac Phenotyping of SARS-CoV-2 in British Columbia: A Prospective Echo Study With Strain Imaging

Jeffrey Yim[SUP] 1 [/SUP], Michael Y C Tsang[SUP] 1 [/SUP], Anand Venkataraman[SUP] 1 [/SUP], Shane Balthazaar[SUP] 1 [/SUP], Ken Gin[SUP] 1 [/SUP], John Jue[SUP] 1 [/SUP], Parvathy Nair[SUP] 1 [/SUP], Christina Luong[SUP] 1 [/SUP], Darwin F Yeung[SUP] 1 [/SUP], Robb Moss[SUP] 1 [/SUP], Sean A Virani[SUP] 1 [/SUP], Jane McKay[SUP] 2 [/SUP], Margot Williams[SUP] 1 [/SUP], Eric C Sayre[SUP] 3 [/SUP], Purang Abolmaesumi[SUP] 4 [/SUP], Teresa S M Tsang[SUP] 5 [/SUP]



Affiliations
Abstract

Background: There is limited data on the residual echocardiographic findings including strain analysis among post-coronavirus disease (COVID) patients. The aim of our study is to prospectively phenotype post-COVID patients.
Methods: All patients discharged following acute COVID infection were systematically followed in the post-COVID-19 Recovery Clinic at Vancouver General Hospital and St. Paul's Hospital. At 4-18 weeks post diagnosis, patients underwent comprehensive echocardiographic assessment. Left ventricular ejection fraction (LVEF) was assessed by 3D, 2D Biplane Simpson's, or visual estimate. LV global longitudinal strain (GLS) was measured using a vendor-independent 2D speckle-tracking software (TomTec).
Results: A total of 127 patients (53% female, mean age 58 years) were included in our analyses. At baseline, cardiac conditions were present in 58% of the patients (15% coronary artery disease, 4% heart failure, 44% hypertension, 10% atrial fibrillation) while the remainder were free of cardiac conditions. COVID-19 serious complications were present in 79% of the patients (76% pneumonia, 37% intensive care unit admission, 21% intubation, 1% myocarditis). Normal LVEF was seen in 96% of the cohort and 97% had normal right ventricular systolic function. A high proportion (53%) had abnormal LV GLS defined as < 18%. Average LV GLS of septal and inferior segments were lower compared to that of other segments. Among patients without pre-existing cardiac conditions, LVEF was abnormal in only 1.9%, but LV GLS was abnormal in 46% of the patients.
Conclusions: Most post-COVID patients had normal LVEF at 4-18 weeks post diagnosis, but over half had abnormal LV GLS.

Keywords: COVID-19; Echocardiography; SARS-CoV-2; Speckle tracking echocardiography; Strain imaging.

 
Back
Top Bottom